Astilbic acid induced COLO 205 cell apoptosis by regulating Bcl-2 and Bax expression and activating caspase-3

被引:0
|
作者
Xiao-liang ZHENG
College of Animal Sciences
State Key Laboratory for New Drug Safety Evaluation (Zhejiang)
机构
关键词
<Keyword>astilbic acid; COLO; 205; cells; apoptosis; cell cycle; bcl-2; genes; Bax protein; mitochondria; caspase;
D O I
暂无
中图分类号
R735.3 [肠肿瘤];
学科分类号
100214 ;
摘要
AIM: To investigate the effect of astilbic acid (3β6β-dihydroxyolean-12-en-27-oic acidAA) on human colorectal carcinoma COLO 205 cell proliferation and apoptosis. METHODS: Proliferation of COLO 205 cells was measued by MTT assay. Content of DNA in COLO 205 cell was measued by modified diphenylamine assay. AA-induced morphological changes was observed with fluorescence microscope and transmission electron microscope . DNA fragmentation was visualized by agarose gel electrophoresis. Apoptosis rate and cell cycle distribution were determined by flow cytometric analysis. Expressions of Bcl-2 and Bax proteins were visioned by immunohistochemical analysis. The change of relative mitochondral transmembrane potential (MTP) in COLO 205 cell was analyzed with FCM after rhodamine 123 staining. RESULTS: The IC50 (96 h) of AA for inhibiting COLO 205 cell proliferation was 61.56±0.34 umol/L. AA induced a marked concentration- and time-dependent inhibition of COLO 205 cell proliferation and reduced the DNA content i
引用
收藏
页码:116 / 121
页数:6
相关论文
共 50 条
  • [1] Astilbic acid induced COLO 205 cell apoptosis by regulating Bcl-2 and Bax expression and activating caspase-3
    Zheng, XL
    Sun, HX
    Liu, XL
    Chen, YX
    Qian, BC
    ACTA PHARMACOLOGICA SINICA, 2004, 25 (08) : 1090 - 1095
  • [2] Oridonin induces apoptosis of HeLa cells via altering expression of Bcl-2/Bax and activating caspase-3/ICAD pathway
    Zhang, CL
    Wu, LJ
    Tashiro, S
    Onodera, S
    Ikejima, T
    ACTA PHARMACOLOGICA SINICA, 2004, 25 (05) : 691 - 698
  • [3] Oridonin induces apoptosis of HeLa cells via altering expression of Bcl-2/Bax and activating caspase-3/ICAD pathway
    Shin-ichi TASHIRO
    Satoshi ONODERA
    Takashi IKEJIMA
    Acta Pharmacologica Sinica, 2004, (05) : 149 - 156
  • [4] Effect of IFNγ on caspase-3, Bcl-2 and Bax expression, and apoptosis in rabbit placenta
    Liu, Z
    Sun, QH
    Yang, Y
    Liu, JM
    Peng, JP
    CYTOKINE, 2003, 24 (05) : 201 - 209
  • [5] Effects of Taspine on Proliferation and Apoptosis by Regulating Caspase-3 Expression and the Ratio of Bax/Bcl-2 in A431 Cells
    Zhang, Yanmin
    Jiang, Qiao
    Wang, Nan
    Dai, Bingling
    Chen, Yinnan
    He, Langchong
    PHYTOTHERAPY RESEARCH, 2011, 25 (03) : 357 - 364
  • [6] Ziyuglycoside II-induced apoptosis in human gastric carcinoma BGC-823 cells by regulating Bax/Bcl-2 expression and activating caspase-3 pathway
    Zhu, A. K.
    Zhou, H.
    Xia, J. Z.
    Jin, H. C.
    Wang, K.
    Yan, J.
    Zuo, J. B.
    Zhu, X.
    Shan, T.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2013, 46 (08) : 670 - 675
  • [7] Dietary High Fluorine Induces Apoptosis and Alters Bcl-2, Bax, and Caspase-3 Protein Expression in the Cecal Tonsil Lymphocytes of Broilers
    Liu, Juan
    Cui, Hengmin
    Peng, Xi
    Fang, Jing
    Zuo, Zhicai
    Wang, Hesong
    Wu, Bangyuan
    Deng, Yuanxin
    Wang, Kangping
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2013, 152 (01) : 25 - 30
  • [8] mRNA expression of Bcl-2, Bax, caspase-3 and -7 cannot be used as a marker for apoptosis in bovine blastocysts
    Vandaele, L.
    Goossens, K.
    Peelman, L.
    Van Soom, A.
    ANIMAL REPRODUCTION SCIENCE, 2008, 106 (1-2) : 168 - 173
  • [9] Hydroxychloroquine-induced apoptosis of chronic lymphocytic leukemia involves activation of caspase-3 and modulation of bcl-2/bax/ratio
    Lagneaux, L
    Delforge, A
    Dejeneffe, M
    Massy, M
    Bernier, M
    Bron, D
    LEUKEMIA & LYMPHOMA, 2002, 43 (05) : 1087 - 1095
  • [10] Paeoniflorin inhibits IL-1β-induced chondrocyte apoptosis by regulating the Bax/Bcl-2/caspase-3 signaling pathway
    Hu, Peng-Fei
    Chen, Wei-Ping
    Bao, Jia-Peng
    Wu, Li-Dong
    MOLECULAR MEDICINE REPORTS, 2018, 17 (04) : 6194 - 6200